From: Sexual function in breast cancer patients: a prospective study from Iran
 | OR (95% CI)* | P | OR (95% CI)** | P |
---|---|---|---|---|
Age | 0.96 (0.94-0.99) | 0.05 | 0.95 (0.93-0.98) | 0.04 |
Education | Â | Â | Â | Â |
Illiterate | 1.0 (ref.) | Â | 1.0 (ref.) | Â |
Primary | 1.61 (0.56-4.61) | 0.36 | 1.32 (0.36-4.80) | 0.66 |
Secondary/higher | 1.47 (0.49-4.40) | 0.48 | 1.28 (0.32-5.01) | 0.72 |
Employment | Â | Â | Â | Â |
Housewife | 1.0 (ref.) | Â | 1.0 (ref.) | Â |
Employed | 1.03 (0.36-2.91) | 0.94 | 1.55 (0.38-6.27) | 0.53 |
Surgery | Â | Â | Â | Â |
Conservative | 1.0 (ref.) | Â | 1.0 (ref.) | Â |
Mastectomy | 1.30 (0.55-3.05) | 0.54 | 1.07 (0.36-3.22) | 0.89 |
Chemotherapy | Â | Â | Â | Â |
No | 1.0 (ref. | Â | 1.0 (ref.) | Â |
Yes | 1.88 (1.10-6.24) | 0.03 | 1.34 (0.25-7.31) | 0.73 |
Radiotherapy | Â | Â | Â | Â |
No | 1.0 (ref.) | Â | 1.0 (ref.) | Â |
Yes | 1.88 (0.73-4.84) | 0.18 | 2.30 (0.57-9.31) | 0.24 |
Endocrine therapy | Â | Â | Â | Â |
No | 1.0 (ref.) | Â | 1.0 (ref.) | Â |
Yes | 3.36 (1.57-7.22) | 0.002 | 3.34 (1.38-8.06) | 0.007 |
Pre-treatment sexual dysfunction | Â | Â | Â | Â |
No | 1.0 (ref.) | Â | 1.0 (ref.) | Â |
Yes | 11.1 (3.78-33.1) | < 0.0001 | 12.3 (3.93-39.0) | < 0.0001 |
Time interval between pre-and post-treatment evaluations (months) | - | - | 1.10 (0.33-3.63) | 0.21 |